Literature DB >> 27287654

Incidence and prevalence of idiopathic interstitial pneumonia and idiopathic pulmonary fibrosis in Korea.

H-E Lee1, J-P Myong1, H-R Kim1, C K Rhee2, H-K Yoon3, J-W Koo1.   

Abstract

SETTING: Although the incidence and prevalence of idiopathic interstitial pneumonia (IIP) and idiopathic pulmonary fibrosis (IPF) have been assessed in Western countries, their epidemiology has not been analysed in Asian countries, including the Republic of Korea.
OBJECTIVE: To estimate the prevalence and incidence of IIP, including IPF, in Korea, using a large, nationwide database.
DESIGN: The Health Insurance Review and Assessment Services claims database, which includes information on every patient with diagnostic codes for IPF and IIP from 2010 to 2013, was reviewed. Age- and sex-specific IPF and IIP prevalence and incidence rates were estimated.
RESULTS: Among Korean males and females, IPF prevalence from 2010 to 2013 was estimated at respectively 39.7 and 24.3 per 100 000 population, while IIP prevalence was estimated at respectively 97.1 and 66.5/100 000. The annual incidence rates among Korean males and females during 2011 and 2012 were respectively 16.4 and 9.7/100 000, for IPF, and respectively 42.3 and 27.5/100 000 for IIP.
CONCLUSIONS: IPF is more prevalent in Korea than previously reported; its prevalence may be similar to or higher than in the United States and in European countries.

Entities:  

Mesh:

Year:  2016        PMID: 27287654     DOI: 10.5588/ijtld.16.0003

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  10 in total

1.  Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study.

Authors:  Dragana M Jovanovic; Martina Šterclová; Nesrin Mogulkoc; Katarzyna Lewandowska; Veronika Müller; Marta Hájková; Michael Studnicka; Jasna Tekavec-Trkanjec; Simona Littnerová; Martina Vašáková
Journal:  Respir Res       Date:  2022-05-27

2.  Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology.

Authors:  Yuanyuan Zhong; Lingli Hu; Wenjing Chen; Bin Wang; Jing Sun; Jingcheng Dong
Journal:  BMC Complement Med Ther       Date:  2022-06-07

3.  The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis.

Authors:  Andreas Guenther; Ekaterina Krauss; Silke Tello; Jasmin Wagner; Bettina Paul; Stefan Kuhn; Olga Maurer; Sabine Heinemann; Ulrich Costabel; María Asunción Nieto Barbero; Veronika Müller; Philippe Bonniaud; Carlo Vancheri; Athol Wells; Martina Vasakova; Alberto Pesci; Matteo Sofia; Walter Klepetko; Werner Seeger; Fotios Drakopanagiotakis; Bruno Crestani
Journal:  Respir Res       Date:  2018-07-28

4.  Family-based case-control study of exposure to household humidifier disinfectants and risk of idiopathic interstitial pneumonia.

Authors:  Dirga Kumar Lamichhane; Jong-Han Leem; Sang-Min Lee; Hyeon-Jong Yang; Jaiyong Kim; Jong-Hyun Lee; Jung Keun Ko; Hwan Cheol Kim; Dong-Uk Park; Hae-Kwan Cheong
Journal:  PLoS One       Date:  2019-09-05       Impact factor: 3.240

5.  Fatigue in idiopathic pulmonary fibrosis measured by the Fatigue Assessment Scale during antifibrotic treatment.

Authors:  Line Kølner-Augustson; Thomas Skovhus Prior; Vibeke Skivild; Anette Aalestrup; Elisabeth Bendstrup
Journal:  Eur Clin Respir J       Date:  2020-11-30

6.  Pulmonary Daoyin as a traditional Chinese medicine rehabilitation programme for patients with IPF: A randomized controlled trial.

Authors:  Miao Zhou; Hailong Zhang; Fenglei Li; Zhefeng Yu; Chengbo Yuan; Brian Oliver; Jiansheng Li
Journal:  Respirology       Date:  2020-11-08       Impact factor: 6.424

7.  The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis.

Authors:  Di Yang; Peng Xu; Haibi Su; Wen Zhong; Jie Xu; Zhenghua Su; Xinhua Liu
Journal:  Cell Death Dis       Date:  2022-01-17       Impact factor: 8.469

8.  A review of current studies on cellular and molecular mechanisms underlying pulmonary fibrosis induced by chemicals.

Authors:  Ha Ryong Kim; Da Young Shin; Kyu Hyuck Chung
Journal:  Environ Health Toxicol       Date:  2018-09-28

9.  Occurrence of Idiopathic Pulmonary Fibrosis in Italy: Latest Evidence from Real-World Data.

Authors:  Marica Iommi; Martina Bonifazi; Andrea Faragalli; Lara Letizia Latini; Federico Mei; Liana Spazzafumo; Edlira Skrami; Luigi Ferrante; Flavia Carle; Rosaria Gesuita
Journal:  Int J Environ Res Public Health       Date:  2022-02-22       Impact factor: 3.390

Review 10.  Global incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Toby M Maher; Elisabeth Bendstrup; Louis Dron; Jonathan Langley; Gerald Smith; Javaria Mona Khalid; Haridarshan Patel; Michael Kreuter
Journal:  Respir Res       Date:  2021-07-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.